Search research articles
Contact Us
Filters
Showing results (41-50 of 164) with videos related to
Page
of 17
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2016
Sequential Use of ALK Inhibitors: An Optional Approach
Kentaro Ito, Osamu Hataji, Hajime Fujimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2020
Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer
Yuta Adachi, Kentaro Ito, Yuko Hayashi, et al.
Translational Lung Cancer Research
|
June 24, 2021
Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials
Hiromi Matsumoto, Nobuyuki Horita, Kentaro Ito, et al.
Applied Optics
|
May 4, 2004
Penetration of high-intensity Er:YAG laser light emitted by IR hollow optical fibers with sealing caps in water
Katsumasa Iwai, Yi-Wei Shi, Masashi Endo, et al.
International Journal of Molecular Sciences
|
April 13, 2024
Human Rad51 Protein Requires Higher Concentrations of Calcium Ions for D-Loop Formation than for Oligonucleotide Strand Exchange
Axelle Renodon-Corniere, Tsutomu Mikawa, Naoyuki Kuwabara, et al.
Biochemical and Biophysical Research Communications
|
July 12, 2011
Distinct expression patterns of the subunits of the CCR4-NOT deadenylase complex during neural development
Chuan Chen, Kentaro Ito, Akinori Takahashi, et al.
Respiratory Investigation
|
May 21, 2019
Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria
Tadashi Sakaguchi, Kentaro Ito, Kazuki Furuhashi, et al.
Cancers
|
October 14, 2022
Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?
Satoshi Ikeda, Tateaki Naito, Satoru Miura, et al.
JAMA Oncology
|
March 28, 2024
Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung Cancer
Kentaro Ito, Yuta Suzuki, Tadashi Sakaguchi, et al.
Plos Genetics
|
August 29, 2014
Multiple regulation of Rad51-mediated homologous recombination by fission yeast Fbh1
Yasuhiro Tsutsui, Yumiko Kurokawa, Kentaro Ito, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 164) with videos related to
Sort By:
Page
of 17
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2016
Sequential Use of ALK Inhibitors: An Optional Approach
Kentaro Ito, Osamu Hataji, Hajime Fujimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2020
Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer
Yuta Adachi, Kentaro Ito, Yuko Hayashi, et al.
Translational Lung Cancer Research
|
June 24, 2021
Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials
Hiromi Matsumoto, Nobuyuki Horita, Kentaro Ito, et al.
Applied Optics
|
May 4, 2004
Penetration of high-intensity Er:YAG laser light emitted by IR hollow optical fibers with sealing caps in water
Katsumasa Iwai, Yi-Wei Shi, Masashi Endo, et al.
International Journal of Molecular Sciences
|
April 13, 2024
Human Rad51 Protein Requires Higher Concentrations of Calcium Ions for D-Loop Formation than for Oligonucleotide Strand Exchange
Axelle Renodon-Corniere, Tsutomu Mikawa, Naoyuki Kuwabara, et al.
Biochemical and Biophysical Research Communications
|
July 12, 2011
Distinct expression patterns of the subunits of the CCR4-NOT deadenylase complex during neural development
Chuan Chen, Kentaro Ito, Akinori Takahashi, et al.
Respiratory Investigation
|
May 21, 2019
Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria
Tadashi Sakaguchi, Kentaro Ito, Kazuki Furuhashi, et al.
Cancers
|
October 14, 2022
Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?
Satoshi Ikeda, Tateaki Naito, Satoru Miura, et al.
JAMA Oncology
|
March 28, 2024
Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung Cancer
Kentaro Ito, Yuta Suzuki, Tadashi Sakaguchi, et al.
Plos Genetics
|
August 29, 2014
Multiple regulation of Rad51-mediated homologous recombination by fission yeast Fbh1
Yasuhiro Tsutsui, Yumiko Kurokawa, Kentaro Ito, et al.
Page
of 17